Biosimilars & Innovator Biologics
June 2021Purchase Recording
Missed us? You Can Still Access this Unique Conference Content.
The 12th Summit on Biosimilars & Innovator Biologics took place June 22-23, 2021. This one-of-a-kind event is loaded with legal, regulatory and commercial strategies for the innovator and biosimilars marketplace.
Recreate the conference experience as if you were viewing the event live through our conference on demand option. With a simple keystroke, you will have access to in-depth and timely information on the latest legal and regulatory developments impacting the biosimilars industry.
- Hear from the “who’s who” of leading biosimilar and innovator biologic companies to discuss, debate, and analyze the latest trends, judicial rulings and legislative developments.
- Listen to preeminent legal minds in this area and access the information you need to help you master critical competencies like naming, labeling, interchangeability and promotion and skinny-labeling Post-GSK v. Teva.
- Develop new strategies for the future that will address the future of patent thickets, challenging patents on reference drugs, diversity and professional responsibility in IP and Biologics.